AbbVie has brought Liz Dorney-Wilcox on board as their Director of Executive Development, search completed by Hanold Associates. Liz will bring a depth of knowledge to the Executive Development team, which she cultivated throughout her career with Bank of America, Dell and General Electric. In October 2011, Abbott announced plans to separate into two publicly traded companies, one in diversified medical products and the other, AbbVie, in research-based pharmaceuticals. AbbVie, a Fortune 200 company, is a research-based pharmaceutical company with a broad and sustainable portfolio of market-leading proprietary pharmaceuticals and biologics sold worldwide.
